Uzbekistan: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in Uzbekistan

In 2021, the Uzbek medicaments containing corticosteroid hormones market was finally on the rise to reach $X after three years of decline. In general, consumption, however, recorded a prominent increase. As a result, consumption reached the peak level and is likely to continue growth in the immediate term.

Production of Medicaments Containing Corticosteroid Hormones in Uzbekistan

In value terms, medicaments containing corticosteroid hormones production soared to $X in 2021 estimated in export price. In general, production, however, showed a abrupt descent. Medicaments containing corticosteroid hormones production peaked at $X in 2017; however, from 2018 to 2021, production failed to regain momentum.

Exports of Medicaments Containing Corticosteroid Hormones

Exports from Uzbekistan

In 2021, after four years of growth, there was significant decline in shipments abroad of medicaments containing corticosteroid hormones, when their volume decreased by -89.3% to X tons. Overall, exports, however, saw a significant expansion. The growth pace was the most rapid in 2020 when exports increased by 670% against the previous year. As a result, the exports attained the peak of X tons, and then shrank notably in the following year.

In value terms, medicaments containing corticosteroid hormones exports reduced sharply to $X in 2021. Over the period under review, exports, however, enjoyed significant growth. The growth pace was the most rapid in 2020 when exports increased by 868%. As a result, the exports reached the peak of $X, and then shrank notably in the following year.

Exports by Country

India (X tons) was the main destination for medicaments containing corticosteroid hormones exports from Uzbekistan, with a 61% share of total exports. Moreover, medicaments containing corticosteroid hormones exports to India exceeded the volume sent to the second major destination, Georgia (X kg), threefold. The third position in this ranking was held by Tajikistan (X kg), with a 15% share.

From 2017 to 2021, the average annual growth rate of volume to India stood at -57.1%. Exports to the other major destinations recorded the following average annual rates of exports growth: Georgia (-15.4% per year) and Tajikistan (+92.6% per year).

In value terms, India ($X) emerged as the key foreign market for medicaments containing corticosteroid hormones exports from Uzbekistan, comprising 66% of total exports. The second position in the ranking was taken by Georgia ($X), with a 15% share of total exports. It was followed by Tajikistan, with a 13% share.

From 2017 to 2021, the average annual rate of growth in terms of value to India stood at +138.7%. Exports to the other major destinations recorded the following average annual rates of exports growth: Georgia (+34.9% per year) and Tajikistan (+747.3% per year).

Export Prices by Country

In 2021, the average medicaments containing corticosteroid hormones export price amounted to $X per ton, rising by 406% against the previous year. Over the period under review, the export price posted a significant expansion. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

Average prices varied somewhat for the major overseas markets. In 2021, the countries with the highest prices were India ($X per ton) and Georgia ($X per ton), while the average price for exports to Kyrgyzstan ($X per ton) and Tajikistan ($X per ton) were amongst the lowest.

From 2017 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to India (+456.4%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports into Uzbekistan

Medicaments containing corticosteroid hormones imports into Uzbekistan dropped rapidly to X tons in 2021, which is down by -79.8% against the year before. Over the period under review, imports continue to indicate a dramatic curtailment. The pace of growth was the most pronounced in 2018 when imports increased by 60% against the previous year. Imports peaked at X tons in 2020, and then reduced notably in the following year.

In value terms, medicaments containing corticosteroid hormones imports contracted slightly to $X in 2021. In general, total imports indicated a buoyant increase from 2017 to 2021: its value increased at an average annual rate of +11.4% over the last four years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +53.9% against 2017 indices. The pace of growth appeared the most rapid in 2020 with an increase of 49% against the previous year. As a result, imports attained the peak of $X, and then shrank modestly in the following year.

Imports by Country

India (X tons), Germany (X tons) and the Netherlands (X tons) were the main suppliers of medicaments containing corticosteroid hormones imports to Uzbekistan, together comprising 24% of total imports. Latvia, Russia, Ukraine, Switzerland, Turkey, Slovenia, Romania, China and Hungary lagged somewhat behind, together comprising a further 37%.

From 2017 to 2021, the biggest increases were recorded for Turkey (with a CAGR of +79.0%), while purchases for the other leaders experienced mixed trend patterns.

In value terms, the largest medicaments containing corticosteroid hormones suppliers to Uzbekistan were Germany ($X), the Netherlands ($X) and Latvia ($X), with a combined 23% share of total imports. These countries were followed by Russia, Ukraine, Slovenia, Romania, India, China, Hungary, Switzerland and Turkey, which together accounted for a further 28%.

Among the main suppliers, Switzerland, with a CAGR of +1,192.7%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average medicaments containing corticosteroid hormones import price stood at $X per ton in 2021, picking up by 378% against the previous year. Over the period under review, the import price enjoyed a significant increase. As a result, import price attained the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Germany ($X per ton), while the price for Switzerland ($X per ton) was amongst the lowest.

From 2017 to 2021, the most notable rate of growth in terms of prices was attained by Ukraine (+88.5%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :